Purpose
Forensic Analysis; Exposure Monitoring/Abuse Monitoring. Over the last six years, NMS Labs has continually invested in research and intelligence gathering, then rapid test development and thorough validation to ensure we are offering testing for the most current synthetic cannabinoids in the rapidly changing designer drug/NPS arena. Our commitment to forensic defensibility for our tests means that compounds identified in this screening test will be confirmed by additional testing, included in the price of the test. Please contact NMS Labs for additional information
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80307
New York State Approval Status

Approved

Known Interference(s)
ADMB-CHMINACA [LC-MS/MS]: AB-CHMINACA
Turnaround Time

5 days (If Positive: 12 days)

Test Includes
1 ADMB-FUBINACA ADB-FUBINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1.0 Synthetic Cannabinoid
2 5-fluoro-PICA 3,3-dimethylbutanoic acid 5-fluoro MDMB-PICA metabolite 7 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
3 5-fluoro-PINACA 3-methylbutanoic acid 5-fluoro AMB metabolite 7 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
4 4-fluoro-BINACA 3,3-dimethylbutanoic acid 4-fluoro MDMB BINACA butanoic acid metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
5 FUBINACA 3-methylbutanoic acid AB-FUBINACA metabolite 3 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
6 5-fluoro-PINACA 3,3-dimethylbutanoic acid 5-fluoro-ADB metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
7 FUBINACA 3,3-dimethylbutanoic acid MDMB-FUBINACA metabolite 1 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
8 APP-BINACA APP-BUTINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
9 5-fluoro-MDMB-PICA 5-fluoro-EMB-PICA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
10 MMB-FUBINACA AMB-FUBINACA, FUB-AMB High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
11 5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA 5-fluoro-ADB/5-fluoro-AEB High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.2 Synthetic Cannabinoid
12 MDMB-4en-PINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
13 ADMB-CHMINACA ADB-CHMINACA; MAB-CHMINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid AB-CHMINACA
14 4-fluoro-MDMB-BINACA 4-fluoro-MDMB-BUTINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid

Reflex Tests
Test Code Test Name
5970B Synthetic Cannabinoids Confirmation (Qualitative), Blood
Compliance Statement
This test was developed and its performance characteristics determined by NMS Labs. It has not been cleared or approved by the US Food and Drug Administration.
Specimen Type
Blood
Requested Volume
5 mL
Minimum Volume
1.4 mL
Special Handling
None
Specimen Container
Gray top tube (Sodium Fluoride / Potassium Oxalate)

Additional Collection Instructions

Transport Temperature
Frozen
Light Protection
Not Required
Rejection Criteria
Received Room Temperature. Received Refrigerated.

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: Not Stable
Refrigerated: Not Stable
Frozen (-20 °C): 1 month(s)
1 ADMB-FUBINACA ADB-FUBINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 1.0 Synthetic Cannabinoid
2 5-fluoro-PICA 3,3-dimethylbutanoic acid 5-fluoro MDMB-PICA metabolite 7 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
3 5-fluoro-PINACA 3-methylbutanoic acid 5-fluoro AMB metabolite 7 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
4 4-fluoro-BINACA 3,3-dimethylbutanoic acid 4-fluoro MDMB BINACA butanoic acid metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
5 FUBINACA 3-methylbutanoic acid AB-FUBINACA metabolite 3 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
6 5-fluoro-PINACA 3,3-dimethylbutanoic acid 5-fluoro-ADB metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
7 FUBINACA 3,3-dimethylbutanoic acid MDMB-FUBINACA metabolite 1 High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 5.0 Synthetic Cannabinoid
8 APP-BINACA APP-BUTINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
9 5-fluoro-MDMB-PICA 5-fluoro-EMB-PICA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
10 MMB-FUBINACA AMB-FUBINACA, FUB-AMB High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
11 5-fluoro-MDMB-PINACA / 5-fluoro-EMB-PINACA 5-fluoro-ADB/5-fluoro-AEB High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.2 Synthetic Cannabinoid
12 MDMB-4en-PINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid
13 ADMB-CHMINACA ADB-CHMINACA; MAB-CHMINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid AB-CHMINACA
14 4-fluoro-MDMB-BINACA 4-fluoro-MDMB-BUTINACA High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 0.1 Synthetic Cannabinoid

Interface Map

LOINC® Information

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.